Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01000620740/Details |
|---|---|
| Matična publikacija: |
Croatian medical journal 46 (2005), 3 ; str. 417-422 |
| Glavni autor: | Behrem, Senija (-) |
| Ostali autori: | Žarković, Kamelija (-), Eškinja, Neven, Jonjić, Nives |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: |
| LEADER | 01006caa a2200301 ir4500 | ||
|---|---|---|---|
| 001 | NSK01000620740 | ||
| 003 | HR-ZaNSK | ||
| 005 | 20100301104514.0 | ||
| 007 | ta | ||
| 008 | 061218s2005 ci ||| ||eng | ||
| 035 | |9 (HR-ZaNSK)621982 | ||
| 035 | |a (HR-ZaNSK)000620740 | ||
| 040 | |a HR-ZaNSK |b hrv |c HR-ZaNSK |e ppiak | ||
| 041 | 0 | |a eng | |
| 042 | |a croatica | ||
| 080 | |a 616.831-006-092.18 |2 MRF 1998. | ||
| 100 | 1 | |a Behrem, Senija | |
| 245 | 1 | 0 | |a Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma / |c Senija Behrem, Kamelija Žarković, Neven Eškinja, Nives Jonjić. |
| 300 | |b Ilustr. | ||
| 500 | |a Tema br.: Pathology | ||
| 504 | |a Bibliografija: 24 jed | ||
| 650 | 7 | |a Glioblastom |x Imunohistokemija |2 nskps | |
| 700 | 1 | |a Žarković, Kamelija | |
| 700 | 1 | |a Eškinja, Neven | |
| 700 | 1 | |a Jonjić, Nives | |
| 773 | 0 | |t Croatian medical journal |x 0353-9504 |g 46 (2005), 3 ; str. 417-422 |w nsk.(HR-ZaNSK)000006721 | |
| 981 | |b B32/05 | ||
| 998 | |a luko0612 |a bokp0710 |c sdii100301 | ||